Načítá se...
Phagocytosis checkpoints as new targets for cancer immunotherapy
Cancer immunotherapies that target adaptive immune checkpoints have significantly improved patient outcomes for multiple metastatic and treatment-refractory cancers. Recent studies, however, have demonstrated that innate immune checkpoints, which interfere with the detection and clearance of maligna...
Uloženo v:
| Vydáno v: | Nat Rev Cancer |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7002027/ https://ncbi.nlm.nih.gov/pubmed/31462760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41568-019-0183-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|